Cite

HARVARD Citation

    Hadoux, J. et al. (n.d.). SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma. International journal of cancer. 135 (11), pp. 2711-2720. [Online]. 
  
Back to record